Clinical Trials Browser

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01520558 2017-06-29

CNDO-109-AANK for AML in First Complete Remission (CR1)

Phase 1/2 Unknown

12 enrolled 11 charts

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT03080922 2017-04-04

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Phase 1/2 Unknown

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Recurrence, Leukemia, Myeloid, Acute

NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Phase 1/2 Unknown

10 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT02944162 2016-12-06

CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML

Phase 1/2 Unknown

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01758367 2016-08-31

Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation

Phase 1/2 Unknown

30 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01146262 2016-07-26

CD lam

Phase 1/2 Unknown

5 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

RELAX

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

A Study of TQB3454 Tablets in Patients With Blood Tumors

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Venetoclax and Lintuzumab-Ac225 in AML Patients

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

PA001

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment

Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)

Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia

Multiple CAR-T Cell Therapy Targeting AML

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Study of Palbociclib in MLL-rearranged Acute Leukemias

TRANSATRA

Multi-CAR T Cell Therapy for Acute Myeloid Leukemia

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）

AML

PANOBEST

DCHA as Postremission Therapy for AML With t(8;21)

GLIDE

CNDO-109-AANK for AML in First Complete Remission (CR1)

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML

Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation

CD lam